Skip to main content

and
  1. No Access

    Article

    Effective Separation for New Therapeutic Modalities Utilizing Temperature-responsive Chromatography

    In recent years, drug discovery and therapeutics trends have shifted from a focus on small-molecule compounds to biopharmaceuticals, genes, cell therapy, and regenerative medicine. Therefore, new approaches an...

    Yutaro Maekawa, Eri Ayano, Kenichi Nagase, Hideko Kanazawa in Analytical Sciences (2021)

  2. Article

    Open Access

    Simultaneous analysis of multiple oligonucleotides by temperature-responsive chromatography using a poly(N-isopropylacrylamide)-based stationary phase

    Oligonucleotide therapeutics have contributed remarkably to healthcare, being well suited for the treatment of intractable diseases that are difficult to approach using conventional drug modalities. However, a...

    Yutaro Maekawa, Kaichi Yamazaki, Miwa Ihara in Analytical and Bioanalytical Chemistry (2020)

  3. Article

    Open Access

    Green analytical method for the simultaneous analysis of cytochrome P450 probe substrates by poly(N-isopropylacrylamide)-based temperature-responsive chromatography

    High-performance liquid chromatography (HPLC) is the most common analytical method practiced in various fields and used for analysis of almost all drug compounds in the pharmaceutical industries. During drug d...

    Yutaro Maekawa, Naoya Okamoto, Yuji Okada, Kenichi Nagase in Scientific Reports (2020)

  4. Article

    Open Access

    Pharmacokinetics and Bioequivalence of Memantine Tablet and a New Dry Syrup Formulation in Healthy Japanese Males: Two Single-Dose Crossover Studies

    Memantine hydrochloride, an N-methyl-D-aspartate receptor antagonist, is used to treat Alzheimer’s disease (AD). A new dry syrup formulation containing memantine hydrochloride has been developed to improve med...

    Yutaro Maekawa, Setsuo Hasegawa, Tomoko Ishizuka, Kazuhito Shiosakai in Advances in Therapy (2019)

  5. No Access

    Article

    Effect of DS-8500a, a Novel G Protein-Coupled Receptor 119 Agonist, on the Pharmacokinetics of Rosuvastatin and Atorvastatin in Healthy Subjects

    Non-clinical study data suggest that DS-8500a, a G protein-coupled receptor 119 agonist, exhibits antidiabetic activity, inhibition of some transporters and induction of cytochrome P450 (CYP) 3A. Statins are s...

    Yutaro Maekawa, Hidetoshi Furuie, Manabu Kato in Clinical Drug Investigation (2019)